Professor Peter Falkai suggests promising new directions in schizophrenia treatment

In a comprehensive Genomic Press Interview, distinguished psychiatrist Professor Peter Falkai suggests promising new directions in schizophrenia treatment through his groundbreaking research on brain plasticity and myelin regeneration.

Cybin Inc. Q3 Earnings: Clinical Advances Amid Financial Loss

The TDR Three Key Takeaways: Positive Clinical Progress: Cybin Inc. has reported significant advancements in its clinical programs, notably achieving a primary efficacy endpoint in

February 15, 2024

Despite Dem opposition, House committee advances pandemic preparedness bill sans drug shortage provisions

The House Energy & Commerce Committee advanced its pandemic preparedness reauthorization legislation Wednesday, despite firm opposition from the panel’s Democrats who also reintroduced their own

July 21, 2023

WHO calls for urgent action on rising neurological conditions worldwide

A major new study released by The Lancet Neurology shows that, in 2021, more than 3 billion people worldwide were living with a neurological condition.

March 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.